Ortho-McNeil Conducting Additional Studies To Assess Ortho Evra Blood Clotting Risks
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm updated labeling to include a new bolded warning regarding increased hormone exposure with the patch versus oral contraceptives.
You may also be interested in...
Agile’s Low-Dose Birth Control Patch Heads For Phase III
Many women would rather don a weekly patch than remember to take a pill every day, firm says.
Agile’s Low-Dose Birth Control Patch Heads For Phase III
Many women would rather don a weekly patch than remember to take a pill every day, firm says.
Public Citizen Demands Removal of J&J’s Ortho Evra Patch From Marketplace
Petition to FDA claims drug exposes women to 60 percent more estrogen and may increase the risk of blood clots two-fold.